Pressure BioSciences (OTCQB: PBIO), a leader in the
development and sale of high pressure-based instruments, consumables, and
related services for the global life sciences industry, this morning announced
worldwide publication by independent researchers of more than 20 scientific
papers in 2018 citing advantages of the company’s pressure cycling technology
(“PCT”) platform. The publications, authored by scientists from industry,
government and academia (a number of which are key opinion leaders in their
field) provided a wide range of applications for PBIO’s patented PCT Platform
in cancer research, biomarker discovery, food safety, and proteomic and
molecular biology studies. “We know that scientists have a strong tendency to
rely heavily on data and opinions from colleagues and other experts in their
field,” PBIO’s Global Director of Sales and Marketing Roxana McCloskey stated
in the news release. “We therefore enhanced our marketing efforts during the
second half of 2018 with a concerted effort to forward this large number of
scientific publications to our base of existing and potential customers. We
were pleased to see this effort result in increased interest and sales of our
Barocycler instruments in 2018, which we believe will continue into 2019 as
well.”
To view the full press release, visit http://ibn.fm/yqyer
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the
development and sale of innovative, broadly enabling, pressure-based solutions
for the worldwide life sciences industry. PBIO’s products are based on the
unique properties of both constant (i.e., static) and alternating (i.e.,
pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented
enabling technology platform that uses alternating cycles of hydrostatic
pressure between ambient and ultra-high levels to safely and reproducibly
control bio-molecular interactions (e.g., cell lysis, biomolecule extraction).
The company’s primary focus is in the development of high pressure-based
products for biomarker and target discovery, drug design and development,
biotherapeutics characterization and quality control, food science, soil &
plant biology, forensics, and counter-bioterror applications. Additionally,
PBIO is actively expanding the use of its pressure-based technologies in the
following areas: (1) the use of its recently acquired protein disaggregation
and refolding technology from BaroFold, Inc. to allow entry into the biologics
manufacturing and contract research services sector, and (2) the use of its
recently-patented, scalable, high-efficiency, pressure-based Ultra Shear
Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise
immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality,
homogenized, extended shelf-life or room temperature stable low-acid liquid foods
that cannot be effectively preserved using existing non-thermal
technologies.For more information, visit the company’s website at www.PressureBiosciences.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment